Template:Butalbital/aspirin/caffeine: Difference between revisions
Jump to navigation
Jump to search
(Blanked the page) |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | |||
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Butalbital/aspirin/caffeine|{{fontcolor|#6C7B8B|Butalbital/aspirin/caffeine}}]]''''' | |||
|- | |||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS bultabital, aspirin and caffeine tablet <sup>®</sup> FDA Package Insert | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet indications and usage|Indications and Usage]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet dosage and administration|Dosage and Administration]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet dosage forms and strengths|Dosage Forms and Strengths]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet contraindications|Contraindications]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet warnings and precautions|Warnings and Precautions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet adverse reactions|Adverse Reactions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet drug interactions|Drug Interactions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet use in specific populations|Use in Specific Populations]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet overdosage|Overdosage]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet description|Description]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet clinical pharmacology|Clinical Pharmacology]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet nonclinical toxicology|Nonclinical Toxicology]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet clinical studies|Clinical Studies]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet how supplied storage and handling|How Supplied/Storage and Handling]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet patient counseling information|Patient Counseling Information]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet labels and packages|Labels and Packages]] | |||
|- | |||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Butalbital/aspirin/caffeine | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov] | |||
|- | |||
|} | |||
Latest revision as of 04:08, 12 February 2014
| Butalbital/aspirin/caffeine |
|---|
| BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS bultabital, aspirin and caffeine tablet ® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Dosage Forms and Strengths |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Butalbital/aspirin/caffeine |
| ClinicalTrials.gov |